6 results
Pharmacotherapy for Migraine Prophylaxis 

Who is indicated for migraine prophylaxis? Patients who experience more than 3
despite appropriate acute ... treatment, or those ... #Prophylaxis #Medications ... #Table #Pharmacology ... #Management #Neurology
Migraine Prevention and Prophylaxis
Who to Consider: 
 • ≥ 4 significant headaches or migraine attacks/month
 •
Migraine Prevention ... to acute migraine ... treatments • ... #treatment #prevention ... #prophylaxis #neurology
Triptan Selection - Migraine Management
Choosing triptans:
 • Reponse to given triptan do not predict to others
month to avoid medication-overuse ... response: • Consider preventive ... #Management #treatment ... #neurology #pharmacology ... #neurology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
disequilibrium syndrome • Diagnosis ... nocturnal enuresis • Prevention ... Tolvaptan) • Treatment ... #Nephrology #Pharmacology ... #Medications #Table
Posterior Reversible Encephalopathy Syndrome (PRES) Overview

Clinico-Radiological Syndrome, characterized by:
 • Headache
 • Seizures
 • Altered mental
characterized by: • Headache ... mental status • Headache ... Reversible course Differential ... Electrolyte abnormality, Medication ... #management #neurology
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
spine • MCC- acute ... Diagnosis: • ... axial T1 and T2 Treatment ... decompression #CaudaEquina ... #neurology